Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non-Current Liabilities (2020 - 2025)

Maravai Lifesciences Holdings has reported Other Non-Current Liabilities over the past 6 years, most recently at $36.5 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $36.5 million for Q4 2025, down 30.47% from a year ago — trailing twelve months through Dec 2025 was $36.5 million (down 30.47% YoY), and the annual figure for FY2025 was $36.5 million, down 30.47%.
  • Other Non-Current Liabilities for Q4 2025 was $36.5 million at Maravai Lifesciences Holdings, down from $38.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for MRVI hit a ceiling of $66.5 million in Q1 2022 and a floor of $1.1 million in Q2 2021.
  • Median Other Non-Current Liabilities over the past 5 years was $52.5 million (2024), compared with a mean of $43.1 million.
  • Biggest five-year swings in Other Non-Current Liabilities: surged 4686.19% in 2022 and later tumbled 30.47% in 2025.
  • Maravai Lifesciences Holdings' Other Non-Current Liabilities stood at $1.6 million in 2021, then skyrocketed by 543.92% to $10.0 million in 2022, then skyrocketed by 494.94% to $59.5 million in 2023, then dropped by 11.81% to $52.5 million in 2024, then tumbled by 30.47% to $36.5 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $36.5 million (Q4 2025), $38.0 million (Q3 2025), and $38.2 million (Q2 2025) per Business Quant data.